Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heiner Dreismann joins Myriad's board

This article was originally published in Clinica

Executive Summary

Molecular diagnostics specialist Myriad Genetics (Salt Lake City, Utah) has appointed Heiner Dreismann to its board of directors. Dr Dreismann has over 24 years of experience in the healthcare industry, and currently serves on the boards of several public and private companies in the sector. He worked for Roche from 1985 until 2006, where he held several positions, including President and CEO of its molecular systems division, and head of global business development of Roche Diagnostics. He was one of the early adopters of polymerase chain reaction (PCR) technology, which is now one of the most widely-used techniques in genetics research.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094907

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel